Emergence of a Multidrug-Resistant Enterobacter hormaechei Clinical Isolate from Egypt Co-Harboring mcr-9 and blaVIM-4
Open Access
- 19 April 2020
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 8 (4), 595
- https://doi.org/10.3390/microorganisms8040595
Abstract
This study describes the first full genomic sequence of an mcr-9 and blaVIM-4-carrying multidrug-resistant Enterobacter hormaechei clinical isolate from Egypt. The strain was isolated in April 2015 from the sputum of a patient in Cairo, Egypt. The mcr-9 and blaVIM-4 genes were identified by PCR screening and DNA sequencing; the isolate was subjected to antimicrobial susceptibility testing, conjugation experiments, and whole genomic sequencing. mcr-9 and blaVIM-4 were carried by an IncHI2 plasmid, pAMS-38a (281,121 bp in size); the plasmid also carried genes conferring resistance against sulfonamides (sul1), quinolones (qnrA1), trimethoprim (dfrA1), β-lactams (blaTEM-1B), aminoglycosides (aac (6’)-II, aadA23, aadA2b, and ant(2’’)-Ia). The strain was susceptible to colistin (MIC, qseC/qseB regulatory system located downstream of mcr-9 in Enterobacterales, which is involved in the induction of colistin-resistance. The genetic context of mcr-9 and blaVIM-4 was identified as IS1-mcr-9-IS903-pcoS-∆pcoE-rcnA and intI1-blaVIM-4—aac (6’)-II-dfrA1-∆aadA23-smr-ISPa21-qacE∆1, respectively. This is the first report of an mcr-9 and blaVIM-4 /IncHI2-carrying multidrug-resistant E. hormaechei clinical isolate from Africa and the Middle East. Plasmids of the IncHI2 group and the two insertion sequences (IS1, and IS903) might be the main vehicles for dissemination of mcr-9. Further screening for mcr-9 is essential for identifying its incidence and to prevent its dissemination.Keywords
This publication has 22 references indexed in Scilit:
- Genetic analysis of carbapenemase-producing Gram-negative bacteria isolated from a university teaching hospital in EgyptInfection, Genetics and Evolution, 2019
- mcr-9 , an Inducible Gene Encoding an Acquired Phosphoethanolamine Transferase in Escherichia coli, and Its OriginAntimicrobial Agents and Chemotherapy, 2019
- FRI-2 carbapenemase-producing Enterobacter cloacae complex in the UKJournal of Antimicrobial Chemotherapy, 2017
- Sequencing and comparative genomics analysis of the IncHI2 plasmids pT5282-mphA and p112298-catA and the IncHI5 plasmid pYNKP001-dfrAInternational Journal of Antimicrobial Agents, 2017
- Dissemination of metallo-β-lactamase in Pseudomonas aeruginosa isolates in Egypt: mutation in bla VIM-4APMIS, 2017
- Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast AsiaClinical Microbiology Reviews, 2017
- Emergence of Plasmid-Mediated Colistin Resistance Gene mcr-1 in a Clinical Escherichia coli Isolate from EgyptAntimicrobial Agents and Chemotherapy, 2016
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological studyThe Lancet Infectious Diseases, 2015
- High prevalence of VIM-4 and NDM-1 metallo-β-lactamase among carbapenem-resistant EnterobacteriaceaeJournal of Medical Microbiology, 2013
- VIM-4 carbapenemase-producing Enterobacter cloacae in the United Arab EmiratesClinical Microbiology & Infection, 2012